{"podcast":{"title":"The Vox Markets Podcast","slug":"the-vox-markets-podcast-3914537","podcast_index_feed_id":3914537,"rss_url":"https://audioboom.com/channels/5051662.rss","website_url":"https://audioboom.com/channels/5051662","image_url":"https://audioboom.com/i/40555564.png","author":"jruss88","episode_count":500,"summary":"Vox Markets is revolutionising the way companies engage with all classes of shareholders. Listen here to interviews with company executives and sell-side analysts and fund managers discuss their investment insights.","last_synced_at":"2026-07-24T02:20:32.176878+00:00","page_url":"https://stenobird.com/podcast/the-vox-markets-podcast-3914537"},"episode":{"title":"2445: Poolbeg’s Big Biotech Moment? First Patient Dosed Ahead of Key POLB 001 Data","slug":"2445-poolbeg-s-big-biotech-moment-first-patient-dosed-ahead-of-key-polb-001-data","published_at":"2026-07-13T06:42:52+00:00","page_url":"https://stenobird.com/podcast/the-vox-markets-podcast-3914537/2445-poolbeg-s-big-biotech-moment-first-patient-dosed-ahead-of-key-polb-001-data","show_page_url":"https://stenobird.com/podcast/the-vox-markets-podcast-3914537","url":"https://audioboom.com/posts/8926828","audio_url":"https://dts.podtrac.com/redirect.mp3/audioboom.com/posts/8926828.mp3?modified=1783925012&sid=5051662&source=rss","summary":"Watch on YouTube Poolbeg Pharma has dosed the first patient in its POLB 001 TOPICAL clinical trial, marking the start of a key execution phase for its CRS prevention programme. With UCLH activated, further sites expected, interim data targeted for summer 2026 and partnering discussions ongoing, investors will be watching whether clinical progress can validate the programme’s claimed commercial potential.","meta_description":"Watch on YouTube Poolbeg Pharma has dosed the first patient in its POLB 001 TOPICAL clinical trial, marking the start of a key execution phase for its CRS…","key_points":[],"chapters":[],"topics":[],"duration_seconds":500,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-vox-markets-podcast-3914537/episodes/2445-poolbeg-s-big-biotech-moment-first-patient-dosed-ahead-of-key-polb-001-data/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-vox-markets-podcast-3914537/2445-poolbeg-s-big-biotech-moment-first-patient-dosed-ahead-of-key-polb-001-data.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}